Analyst: Potential Apple product could target GN's market segment
According to Janne Vincent Kjær, senior equity analyst at Jyske Bank, it is most likely that a new Apple product would be aimed at people suffering mild hearing loss – which is the same target group of GN's Jabra Enhance Plus.
.jpg)
BY MARKETWIRE, TRANSLATED BY DANIEL PEDERSEN
On Wednesday afternoon, hearing aid manufacturers GN and Demant's share prices dropped on OMX Copenhagen 25, after rumors began to spread that Apple is investigating whether its Airpods product can be used as a solution for hearing health. The rumors were reported by the Wall Street Journal, referring to sources it says are familiar with Apple's plans.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Apple investigating Airpods as hearing health solution
For subscribers
